Gene expression of ACE2 gene in patients infected with COVID-19 and comparing them with vaccine recipients
Maryam Abdul Kareem Mahmoud, Nagam Khudhair
Department of Biology, College of Education for Women, University of Anbar, Anbar, Iraq.
*Corresponding Author E-mail: maryamqaisy12@gmail.com
ABSTRACT:
COVID-19 virus caused by severe acute respiratory syndrome (SARS-Cov-2) poses a great threat to human life and public health as it enters the body through ACE2 receptors in lung and spreads through respiratory droplets and close contact. The present study aimed to investigate the role of ACE2 and some biomarkers of COVID-19 patients and vaccine recipients. In total , 80 samples divided into 4 groups (healthy, Patient , healthy vaccinated, Patient vaccinated) were studied, with 10 males and 10 females for each group. RNA was extracted from blood and ACE2 gene expression was measured by qRT-PCR , as well as some biomarkers were measured, including CRP, D.dimer, LDH, Ferritin, Urea, and Creatinine, for all study groups. The results also showed that there were significant differences at the level (P ≤ 0.05) of some biochemical variables in males and females in the healthy group, and in the group of patients, and the group of patients receiving the vaccine, the values of vital signs increased to predict the severity of infection, as for kidney functions, which included (Urea, Creatinine). The results showed a high significant difference of Urea level in females compared to males in the healthy and patients groups at the level (P ≤ 0.05), and the results of Creatinine showed a significant difference for males in the patients group at the level (P ≤ 0.05) compared to females. Significant differences for females at the level (P ≤ 0.05) compared to males in the group of those who received the vaccine, the virus caused kidney impairment in severe cases due to its binding to ACE2 found in kidney tubes, causing tissue and kidney damage in general due to the high level of both creatinine urea, and there is a high positive significant relationship between the angiotensin-converting enzyme ACE2 and some biomarkers in cases of Covid-19 and between the biomarkers each other.
KEYWORDS: COVID-19, Vaccine, ACE2, SARS-Cov-2, Gene expression, D-dimer.
INTRODUCTION:
The new Corona virus or severe acute syndrome (SARS-Cov-2) has spread rapidly from Wuhan, Hubei Province, China, to all parts of the world1. The rapid and continuous spread of Covid-19 poses a serious threat to human health in particular and to the global economy in general 2. The virus has spread to all countries and continents around the world, recording 453 million cases and 6.03 deaths3, most patients suffer from high temperature, shortness of breath, cough and pneumonia , and in severe cases it develops into respiratory failure or organ failure4.
Virus detection and diagnosis through the polymerase chain reaction test via nasopharyngeal smear, some laboratory tests and computerized tomography5, as they showed low lymphocytosis and high CRP, Ferritin, D. dimer predicting the severity and severity of infection with the virus6. ACE2 is the entry point of the virus into the human body, which is expressed in lung cells, renal tubules, and vascular endothelium7 . The spike of COVID-19 formed a trimer and interacted with angiotensin-converting enzyme 2 (ACE2), initiating the viral infection. The E-protein could create an ion channel, which facilitated the viral material to enter into the host cell, and an N protein initiated the binding of the host protein to host DNA, while the M protein was important in viral morphogenesis. Accessory proteins included 3a, 6, 7a,7b, 8 and 9b, which were suggested to regulate the immunity of host 89 as shown in Figure 1.
Figure 1. Transmission and life cycle of SARS-CoV-2 causing COVID-19. SARS-CoV-2 is transmitted via respiratory droplets of infected cases to oral and respiratory mucosal cells 10.
The vaccine against COVID-19 is our main hope in tackling the coronavirus pandemic and returning to everyday life 1112, scientists have begun to develop a special vaccine based on live cells mRNA, as a message from the coronavirus is copied and used to make a spike protein that works to enter the human cell because it combines with ACE2 and causes Covid-19 infection 13,14. The protein does not cause infection, but it stimulates the body to recognize the virus and form immune bodies. Vaccines have proven effective by 95% 15,16. So, the aim of the study is to measure the gene expression of ACE2 and compare it with the studied groups, measure biochemical indicators and compare them between males and females in the groups, and know the extent of the effect of the vaccine’s efficacy.
ATERIALS AND METHODS:
1-Sample Collection:
In the period from November 2021 to February 2022, all samples were collected in the private Central Al-Tamyaz Laboratory for pathological analyzes, Ramadi Teaching Hospital, and the Al-Anbar health department. Their ages ranged between (17-75) years, 5ml of blood was withdrawn for 80 samples divided into four groups, each groups includes 20 samples divided into 10 males and 10 females, (Healthy Groups ) ، (Patient Groups ) , (Healthy Vaccine Recipient Groups)، (Patient Vaccine Recipient Groups). In this analysis, according to the ethics of scientific research.
2-Assessment of biomarker levels:
Both of D-dimer ,and ferritin levels are tested using automated Mini-Vidas system (Biomerieux, France). Reference range of less than 500 ng/ml for D-dimer and 28 -390 ng/ml for ferritin. On other hand , CRP were evaluated using a specific automated protein analyzer (PA120) provided by (Shenzhen Genius Electronics Co., Ltd. China 2019). Serum samples for each of the patients and healthy persons were applied to the instrument then the concentrations of CRP is calculated automatically.
3-Assessment of renal function test:
The serum separated from the blood by centrifligation was used, in duplicates, for the estimation of urea and creatinine according to the manufacturer's instructions.
4- Extraction RNA and real time-PCR (qRT-PCR):
500 µL of blood sample was used and 100 µL of Trizol reagent was added to extract the RNA. The RNA was converted into cDNA using a special kit supplied by the Korean company BIONEER according to the company’s instructions. Then real-time quantitative reverse transcription (Real-Time q RT-PCR) technology was used to quantify the gene expression of the study gene ACE2 and the titration gene β-actin as shown in )Table 1). the data were partially calculated using the Livak equation and according to the method 17.
Table 1: shows the primers used in the molecular study.
|
Human Gene |
Sequence 5’ – 3’ |
bp |
NCBI Reference |
|
β-actin |
5´-CTGGAACGGTGAAGGTGACA-3´ |
|
|
|
5´- AAGGGACTTCCTGTAACAATGCA-3´ |
146 |
NM_001101.5 |
|
|
ACE2 |
5´-TTCAAGGAGGCCGAGAAGTTC-3´ |
100 |
AB046569.1 |
|
5´-TCTGAACATTTCCTGGGTCCG-3´ |
5-Statistical analysis
The results were statistically analyzed using the SPSS program (Spss, 2011) and using the Analysis of Variance (ANOVA Table) to calculate the variance, covariance, correlation and test the averages using the least significant difference test L.S.D at the probability level of 0.05. The averages were also compared using the standard error in addition to Duncan's Multiple Range Test at the level of significance (P ≤ 0.01, P ≤ 0.05). The Correlation Matrix Person's Correlation Matrix was used between the biochemical analyzes and the molecular tests using the equation 18.
RESULTS AND DISCUSSION:
Molecular Biology:
The results show in (Fig.1.A) there are significant differences between G2M and between G3M , G4M at the level (P≤ 0.05) ، there are no significant differences between the G2M and G1M at the same level. there were significant differences between the G2F and all groups، there was also a significant difference between the G4F and the G3F at the level of significance (P≤ 0.01). (Fig .1.B) It showed that there was a significant difference in the G2M at the level (P≤ 0.05), as well as the presence of a significant and apparent difference at the level (P≤ 0.05) in G3F and betweenG3M , and there was a significant difference between G4M. And between the G4F , the results showed that there was a significant and high phenotypic difference among the G2F compared with the studied groups and males at the level (P≤ 0.05), as well as the presence of a significant difference among the G3F compared with the males and other groups at the level (P≤ 0.05) , and there was also a seemingly low significant difference among G4F and between males and other groups at the level of significance (P≤ 0.05).
(Fig.1.A) shows the ACE2 gene expression in males and females in the groups studied for COVID-19. G1M healthy males , G2M Patient males, G3M healthy males vaccine recipients, G4M Patient males vaccine recipients, G1F healthy females , G2F Patient females , G3F healthy females vaccine recipients, G4f Patient females vaccine recipients, lowercase letters indicate significant differences at the level (P ≤ 0.05, P ≤ 0.01).
(Fig. 1.B) shows the gene expression of ACE2 gene and the interactions between groups, G1M healthy males , G2M Patient males, G3M healthy males vaccine recipients, G4M males Patient vaccine recipients, G1F healthy females , G2F Patient females , G3F healthy females and vaccine recipients, G4f Patient females vaccine recipients, lowercase letters indicate significant differences at the level (P ≤ 0.05, P ≤ 0.01).
There were no sex-related differences in the activity of ACE2 enzyme in the blood in healthy individuals 19, However, ACE2 enzyme activity in serum was observed to be higher in women older than 55 years compared to women younger than 55 years, with no difference in ACE2 activity in the serum of older and young men. [19] confirmed that there was no difference in ACE2 enzyme level in the serum of men compared to women. Viral respiratory infections are the most common cause of acute asthma exacerbations in children and adults, ACE2 expression was lower in those with high levels of allergic sensitization and asthma compared to healthy people 21. Studies show that the high frequency of Covid-19 in patients receiving ACE inhibitors or angiotensin receptor blockers is not due to these drugs, but because the patients were often older or suffering from high blood pressure or diabetes 22. It is known that high blood pressure significantly reduces ACE2 expression, so patients with high blood pressure are more likely to have ACE2 levels below a certain threshold, making them more susceptible to severe lung disease 23.
Inactivated or attenuated vaccines that contain the S protein expressed in pseudo viruses or virus-like particles can bind to the available ACE2, and the mACE2 complex can bind to ACE2 resulting in an overall decrease of ACE2 resulting in elevated (Ang II) in the same way that the original virus does it dangerously for sick individuals and the elderly, healthy individuals can overcome the vaccine-induced Ang II elevation 24. The official US report found that the death rate for men is 55%, while women are 45% from a biological and immune point of view. Women usually have a stronger and faster immune response than men, while some researchers discovered that estrogen and testosterone may affect the response to the new Corona virus 25 as estrogen regulates ACE2 which has been suggested as a protective mechanism against organ damage by SARS-COV-2 26. Studies have shown the difference between the sexes in the response to vaccines, where women give a response to the vaccine and the formation of higher antibodies to vaccination against most vaccines, diseases such as seasonal influenza, etc. than men 27, Immunity depends on the production of antibodies to achieve self-protection from infectious diseases that require antibodies for resistance. Women tend to show fewer cases and weaker disease cycles when compared to men, and the effect of vaccination to produce protective antibodies to prevent infectious diseases is often better in women compared to men 28 The results of the statistical analysis in (Fig .2) There is a significant difference at the level of (P ≤ 0.05) for D.dimer between males and females in the healthy group, and the presence of a significant difference for ferritin at the level of (P ≤ 0.05 ) in the healthy group.
Fig.2: The average values of biochemical traits for healthy males and females .
The results in (Fig.3) showed that there was a statistically significant difference at the level (P ≤ 0.05) for (Ferritin, D. dimer, LDH) between males and females in the Patient group.
Fig.3: The average values of biochemical traits for Patient males and females .
The results of the statistical analysis in (Fig 4) indicate that there are no statistically significant differences between males and females in the healthy group that received the vaccine.
Fig. 4: The average values of biochemical traits for healthy vaccine recipients males and females .
(Fig.5) showed that there was a statistically significant difference at the level (P ≤ 0.05) for (Ferritin, D.dimer, CRP) between males and females in the Patient vaccine recipients group.
Fig. 5: The average values of biochemical traits for Patient vaccine recipients males and females.
The results in (Fig.6) showed that there was a high significant difference for Urea in females compared to males in the two groups of healthy and Patient people at the level (P ≤ 0.05), while in the group of Patient people who received the vaccine, it showed a significant increase for males at the level (P ≤ 0.05) compared to females.
Fig. 6: Average urea values in males and females between groups.
(Fig.7) The results showed that there was a significant difference in Creatinine for males in the Patient group at the level (P ≤ 0.05) compared to females, as well as significant differences for females at the level (P ≤ 0.05) compared to males in the group of patients who received the vaccine, and no significant differences appeared in the other groups.
Table 2: Show the correlation between biochemical and molecular analyzes.
|
|
2ΔΔCt |
D-dimer |
CRP |
Ferritin |
LDH |
Urea |
Creatinine |
|
2ΔΔCt |
1 |
|
|
|
|
|
|
|
D-dimer |
0.9874** |
1 |
|
|
|
|
|
|
CRP |
0.2484 |
0.2484 |
1 |
|
|
|
|
|
Ferritin |
0.5154** |
0.5154** |
0.3057 |
1 |
|
|
|
|
LDH |
0.4991* |
0.4991** |
-0.0033 |
0.6088** |
1 |
|
|
|
Urea |
0.5157** |
0.5157** |
0.3922 |
0.7586** |
0.4137 |
1 |
|
|
Creatinine |
0.3373 |
0.3373 |
0.2638 |
0.7695** |
0.2315 |
0.7169** |
1 |
Fig. 7: Average Creatinine values in males and females between groups.
Table (2) showed highly significant relationships at the level (0.01) between D.dimer, Ferritin, Urea, LDH with ACE2 , as well as between D.dimer with (Urea, LDH, Ferritin) , also indicated that there is a relationship between Ferritin with ( LDH, Urea, Creatinine) , and also between Urea and Creatinine.
D. dimer is a biological indicator of fibrin formation, It is considered one of the important protein compounds that are produced in the event of blood clots in the body, and its levels are low in normal conditions and high levels within the body indicate the occurrence of pathological conditions and works to break down blood clots 29. Several studies have confirmed that the level of D. dimer in healthy people is lower in males compared to females, Associated with Covid-19 infection with a high level of D. dimer, high levels of D. dimer cause venous thromboembolism, which contributes to respiratory deterioration associated with Covid-19 infection, female sex was a major risk factor for the development of high D. dimer, a study was conducted in more than 20 countries on people who received the vaccine, where high D. dimer was observed in the majority of women aged 55 years or less 303132. The value of Ferritin was also shown , which is a protein for storing iron inside cells and is a sign of iron storage in the blood. Its normal levels in the blood vary its average in males and females before menopause is ˃300 µg/L and ˃200 µg/L in premenopausal women. It is of unlimited value and is released from damaged liver cells and its levels are raised in inflammatory disorders, liver disease, excessive alcohol consumption and malignant diseases. The concentration of ferritin in males is twice its concentration in females, and in a study conducted on people infected with COVID-19, it was noted that all infected individuals, especially severe infections, showed a higher level of ferritin in their blood compared with healthy people 3334. That patients who recovered from COVID-19 disease had a clear decrease in their ferritin level, which confirms that the high level of ferritin in the blood is associated with infection with COVID-19. Therefore, ferritin is an important predictor of infection with COVID-19 3536.
CRP It is an inflammatory protein produced by the liver in acute injuries, and it is raised in several cases, such as inflammation, cardiovascular disease, viral and bacterial infections, Where CRP binds to pathogens and promotes their elimination by phagocytic cells that act as the host's first line of defense, in healthy subjects CRP is found in plasma and is usually less than 10 mg/L in males and females, Also CRP is considered an early sign of ICU admission as CRP level higher than 100mg/L was found to be associated with increased ICU and mortality 3738 . In a recent study, it was shown that the performance of CRP was better than other indicators in predicting Covid-19. In Covid-19 patients, the elevated LDH level is an expression of severe lung damage and shortness of breath as a result of the abnormal inflammatory state, the LDH concentration in males is higher compared to females, and the high level of LDH was also associated with the severity of covid-19 infection, organ dysfunction and coagulation, as well as with deaths in patients from severe acute respiratory syndrome SARS-Cov-2, and also indicate tissue injury and lack of oxygen, and these high levels are an important factor for predicting Covid-19 infection and an indicator of mortality in patients with septicemia diseases 3940. Where the level of LDH increased during acute pneumonia and indicates the extent of lung infection with the virus and shortness of breath, The respiratory system is not the only one that has been affected by the Corona virus, as well as complications resulting from kidney impairment, especially in patients with severe infection, for angiotensinogen ACE2 that is expressed in the renal tubular epithelium 41. Also, a study conducted by Xiang et al., 2021 showed that SARS-Cov-2 causes direct and dangerous injury to the kidneys through its binding to the ACE2 receptor and it is detected by analyzing urea and Creatinine.
Creatinine is present in the bloodstream in proportions it is the product of the metabolic breakdown of muscles and protein and is excreted in the event of muscle rupture, as it was used as an indicator of tissue and muscle damage and to determine the amount of damage through its level in the blood, through which the functions and effectiveness of the kidneys are measured. Kidney damage due to eating large quantities of proteins that are given to patients in intensive care, as well as the antidiuretic hormone (ADH) produced frequently, which led to a high uptake of urea by the renal marrow 43.
Table (2) indicates that there are highly significant relationships at the level (0.01) between (Urea, D. dimer, and ferritin) each other and with the ACE2 gene in all study groups. ACE2 in cells and according to the results of our study, females have higher levels of D. dimer and Urea compared to males in normal cases and cases of infection with the virus , the presence of ACE2 in the kidneys and the association of blood pressure and kidney diseases with males and that high Blood pressure reduces the expression of ACE2 44, estrogen is known to up-regulate ACE2 and up regulation of ACE2 reduces inflammation and protects against cell injury. It acts as a protective mechanism against SARS-Cov-2 infection and estrogen also modulates pneumonia and lung damage. caused by the virus and that the level of estrogen in women is higher than in men, which gives women a higher immune and adaptive response to viral infection 45, which confirms that women have a higher incidence of Covid-19 disease than men, but Due to the increased level of estrogen in women A gives it a higher resistance to the virus than males, so it will be less affected than males .
CONCLUSIONS:
The results show that ACE2 is an essential receptor for Covid-19, and also indicates that there is a significant difference between males and females in the level of gene expression of the ACE2 gene in the study groups. And a stronger and faster immune response to vaccines in females compared to males. The values of some vital indicators increased to predict infection and severity of the virus, and there were significant differences between males and females, as the values of )D. dimer, CRP) were higher when Patients with females than males . As for the value of (Ferritin, LDH) recorded a higher increase in males than females. The infection will not be limited to the respiratory system only. The virus caused weakness in the liver and kidneys in severe cases due to its association with ACE2 found in renal tubes, causing tissue and kidney damage in general due to the high level of both Creatinine urea , the value of Urea in females in all cases, except in the category of Patient and vaccine recipients, recorded a higher increase in males than females, and values of Creatinine level decreased in males when receiving the vaccine compared to females, There is a positive, high moral relationship between ACE and some vital indicators in cases of Covid-19.
REFERENCE:
1. Lai, C.-C. et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. J. Microbiol. Immunol. Infect. 2020; 53: 404–412 (2020).https://doi.org/10.1016/j.jmii.2020.02.012
2. Valiente, C. et al. Psychological adjustment in Spain during the COVID-19 pandemic: positive and negative mental health outcomes in the general population. Span. J. Psychol. 2021; 24.
3. Nande, A., Adlam, B., Sheen, J., Levy, M. Z. and Hill, A. L. Dynamics of COVID-19 under social distancing measures are driven by transmission network structure. PLoS Comput. Biol. 2021; 17: e1008684. DOI: https://doi.org/10.1017/SJP.2021.7
4. Tian, J. et al. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020; 21: 893–903. https://doi.org/10.1016/S1470-2045(20)30309-0.
5. Peng, L. et al. SARS‐CoV‐2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens. J. Med. Virol. 2020; 92: 1676–1680. https://doi.org/10.1002/jmv.25936.
6. Pereira, M. A. M. et al. Laboratory findings in SARS-CoV-2 infections: State of the art. Rev. Assoc. Med. Bras. 2020; 66: 1152–1156. https://doi.org/10.1590/1806-9282.66.8.1152.
7. Ji, H.-L., Zhao, R., Matalon, S. and Matthay, M. A. Elevated plasmin (ogen) as a common risk factor for COVID-19 susceptibility. Physiol. Rev. 2020. https://doi.org/10.1152/physrev.00013.2020.
8. Naqvi, A. A. T. et al. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach. Biochim. Biophys. Acta (BBA)-Molecular Basis Dis. 2020; 1866: 165878. https://doi.org/10.1016/j.bbadis.2020.165878.
9. Jain, R. S., Jain, T. G. and Ishikar, S. K. Impact of COVID-19 on changing habits and health issues of the public. Asian J. Manag. 2020; 11: 524–528. DOI : 10.5958/2321-5763.2020.00077.3.
10. Funk, C. D., Laferrière, C. and Ardakani, A. A snapshot of the global race for vaccines targeting SARS-CoV-2 and the COVID-19 pandemic. Front. Pharmacol. 2020; 11: 937. https://doi.org/10.3389/fphar.2020.00937.
11. Kim, Y. C., Dema, B. and Reyes-Sandoval, A. COVID-19 vaccines: breaking record times to first-in-human trials. NPJ Vaccines. 2020; 5: 1–3. https://doi.org/10.1038/s41541-020-0188-3.
12. Ayedee, N. and Kumar, A. Indian Education System and growing number of online Conferences: Scenario under COVID-19. Asian J. Manag. 2020; 11: 395–401. DOI: 10.5958/2321-5763.2020.00060.8.
13. Sette, A. and Crotty, S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021; 184: 861–880. https://doi.org/10.1016/j.cell.2021.01.007
14. Toshniwal, A. and Narendran, R. An intertwined approach to workplace happiness, workplace motivation and workplace stress: A study on COVID-19 lockdown. Asian J. Manag. 2020; 11: 407–412. DOI: 10.5958/2321-5763.2020.00062.1.
15. Leslie, M. T cells found in coronavirus patients ‘bode well’for long-term immunity. at 2020. DOI: 10.1126/science.368.6493.809.
16. Sarkar, N., Mandal, B. K. and Paul, S. Activity, Effect on Human and Salvation from effect of COVID-19. Strain. 2021; 229: 103. DOI: 10.52711/2321-5763.2021.00035.
17. Livak, K. J. and Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods. 2001; 25: 402–408. https://doi.org/10.1006/meth.2001.1262.
18. Steel, R. G. D. and Torrie, J. H. Principles and procedures of statistics, a biometrical approach. (McGraw-Hill Kogakusha, Ltd., 1980). DOI: 10.51721/2621-5853.21980.00043.
19. Fernández-Atucha, A. et al. Sex differences in the aging pattern of renin–angiotensin system serum peptidases. Biol. Sex Differ. 2017; 8: 1–8. https://doi.org/10.1186/s13293-017-0128-8.
20. Bernardi, S. et al. Sex differences in proatherogenic cytokine levels. Int. J. Mol. Sci. 2020; 21: 3861. https://doi.org/10.3390/ijms21113861.
21. Jackson, D. J. et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J. Allergy Clin. Immunol. 2020; 146: 203–206. DOI:https://doi.org/10.1016/j.jaci.2020.04.009.
22. Procko, E. The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2. BioRxiv (2020). doi: 10.1101/2020.03.16.994236
23. Crackower, M. A. et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002; 417: 822–828. https://doi.org/10.1038/nature00786
24. Rahman, M. A. et al. Data-driven dynamic clustering framework for mitigating the adverse economic impact of Covid-19 lockdown practices. Sustain. cities Soc. 2020; 62: 102372. https://doi.org/10.1016/j.scs.2020.102372.
25. Arianna Di Stadio, M. D., Ralli, M. and Ricci, G. Gender differences in COVID-19 infection. The estrogen effect on upper and lower airways. Can it help to figure out a treatment. Eur Rev Med Pharmacol Sci. 2020; 24: 5195–5196. DOI: 10.26355/eurrev_202005_21298
26. Bukowska, A. et al. Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men. Exp. Biol. Med. 2017; 242: 1412–1423. https://doi.org/10.1177/1535370217718808.
27. Voigt, E. A. et al. Sex differences in older adults’ immune responses to seasonal influenza vaccination. Front. Immunol. 2019; 10: 180. https://doi.org/10.3389/fimmu.2019.00180.
28. Klein, S. L. and Flanagan, K. L. Sex differences in immune responses. Nat. Rev. Immunol. 2016; 16: 626–638. https://doi.org/10.1038/nri.2016.90
29. Tasić, N., Paixão, T. R. L. C. and Gonçalves, L. M. Biosensing of D-dimer, making the transition from the central hospital laboratory to bedside determination. Talanta. 2020; 207: 120270. https://doi.org/10.1016/j.talanta.2019.120270
30. Mallapaty, S. and Callaway, E. What scientists do and don’t know about the Oxford-AstraZeneca COVID vaccine. Nature. 2021; 592: 15–17. DOI: 10.1038/d41586-021-00785-7.
31. Iqbal, Z. and Tanty, G. Impact of Covid on Banking Industry in India. 2021. DOI : 10.5958/2231-0657.2021.00011.2.
32. Aslan, I., Ochnik, D. and Çınar, O. Exploring perceived stress among students in Turkey during the COVID-19 pandemic. Int. J. Environ. Res. Public Health. 2020; 17: 8961. doi.org/10.3390/ijerph17238961.
33. Yu, B. et al. Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis. J. Thromb. Thrombolysis. 2020; 50: 548–557. https://doi.org/10.1007/s11239-020-02171-y.
34. Solanki, R. and Singh, K. Covid 19 home confinement effects on consumer’s food consumption and eating habits. Age (in years) 20, 10 (2021). DOI: 10.52711/2321-5763.2021.00076.
35. Taneri, P. E. et al. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. Eur. J. Epidemiol. 2020; 35: 763–773. https://doi.org/10.1007/s10654-020-00678-5.
36. Kumar, A. Emotional intelligence can help healthcare professionals and managers: A way deal COVID-19 pandemic. Asian J. Manag. 2021; 12: 353–358. DOI: 10.52711/2321-5763.2021.00053
37. Chaudhary, N. and Anand, S. Effectiveness of online payment system during COVID-19. Education. 2022; 109: 50–54. DOI: 10.52711/2321-5763.2022.00011.
38. Koozi, H., Lengquist, M. and Frigyesi, A. C-reactive protein as a prognostic factor in intensive care admissions for sepsis: A Swedish multicenter study. J. Crit. Care. 2020; 56: 73–79. https://doi.org/10.1016/j.jcrc.2019.12.009.
39. Vidal-Cevallos, P. et al. Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study. Ann. Hepatol. 2021; 24: 100338. doi: 10.1016/j.aohep.2021.100354.
40. Vishnu, P. K., Anil, P. V and Vyshak, P. K. Adaptation towards Green banking; exploring acceptance and awareness among stakeholders of Banking Industry; A Post COVID-19 outbreak analysis. Asian J. Manag. 2022; 13: 186–192. DOI: 10.52711/2321-5763.2022.00034.
41. Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020; 181: 271–280. https://doi.org/10.1016/j.cell.2020.02.052.
42. Xiang, H.-X. et al. Renal dysfunction and prognosis of COVID-19 patients: a hospital-based retrospective cohort study. BMC Infect. Dis. 2021; 21: 1–7. https://doi.org/10.1186/s12879-021-05861-x.
43. Cucinotta, D. and Vanelli, M. WHO declares COVID-19 a pandemic. Acta Bio Medica Atenei Parm. 2020; 91: 157. doi: 10.23750/abm.v91i1.9397.
44. Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020; 367: 1260–1263.
45. Vermillion, M. S., Ursin, R. L., Attreed, S. E. and Klein, S. L. Estriol reduces pulmonary immune cell recruitment and inflammation to protect female mice from severe influenza. Endocrinology. 2018; 159: 3306–3320. DOI: 10.1126/science.abb2507.
Received on 22.07.2022 Modified on 12.11.2022
Accepted on 05.02.2023 © RJPT All right reserved
Research J. Pharm. and Tech 2023; 16(8):3601-3607.
DOI: 10.52711/0974-360X.2023.00594